# Cognition and MRI Markers in MS Patients With Aubagio® Treatment

> **NCT03768648** · NA · COMPLETED · sponsor: **University Hospital, Bordeaux** · enrollment: 75 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **OTHER:** Clinical assessment
- **OTHER:** Ecological evaluation
- **OTHER:** Neuropsychological evaluation
- **OTHER:** Psychological evaluation
- **DEVICE:** MRI Evaluation

## Key facts

- **NCT ID:** NCT03768648
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-21
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-02-23
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2023-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03768648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03768648, "Cognition and MRI Markers in MS Patients With Aubagio® Treatment". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03768648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*